AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.


8 June 2021

Novel tool to visualize antibiotic resistance

5 June 2021

The plot thickens: data visualization in antimicrobial resistance research

5 June 2021

Adaptive Phage Therapeutics Initiates Phase 1/2 Trial of PhageBank™ in Urinary Tract Infections

3 June 2021

SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

2 June 2021

Nanotherapeutics Hub joins iiCON to help strengthen UK’s infectious disease products pipeline

2 June 2021

CARB-X IS FUNDING SWISS PHARMA COMPANY BIOVERSYS TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT INFECTIONS CAUSED BY MULTIDRUG-RESISTANT ESKAPE PATHOGENS

28 May 2021

Fight Against Antibiotic-Resistant Bacteria Has a Glowing New Weapon

28 May 2021

Drug-resistant Staphylococcus Aureus Bacteria Detection with the Combination of Surface-enhanced Raman Spectroscopy and Deep Learning Techniques

27 May 2021

Liverpool platform will support nanomedicine developers

27 May 2021

Mathematical model predicts effect of bacterial mutations on antibiotic success

27 May 2021

CARB-X IS FUNDING SNIPR BIOME TO DEVELOP A CRISPR-ENGINEERED DRUG TO ERADICATE ESCHERICHIA COLI (E. COLI) BACTERIA IN CANCER PATIENTS TO PREVENT DEADLY INFECTIONS

25 May 2021

WHO and Switzerland launch global BioHub for pathogen storage, sharing and analysis

25 May 2021

Improving outcomes and antibiotic stewardship (IOAS) for patients with Gram-positive bloodstream infections through use of rapid testing: a quasi-experimental multicentre study of the Accelerate PhenoTest™ BC Kit

25 May 2021

Innovation from Halton and LED Tailor – a disinfection blue light system that kills microbes in operating rooms and brings hope to the antibiotic resistance fight in the hospitals

25 May 2021

U.K. Pitches Radical Investment Plans to Fight Killer Bacteria

22 May 2021

TGAR Foundation and AMR Insights to join forces

21 May 2021

Three-Dimensional Micropatterning Deters Early Bacterial Adherence and Can Eliminate Colonization

21 May 2021

Study identifies colistin resistance drug target

20 May 2021

CARB-X IS FUNDING BASILEA PHARMACEUTICA TO DEVELOP A NEW CLASS OF ANTIBIOTICS TO TREAT DRUG-RESISTANT GRAM-NEGATIVE BACTERIA

20 May 2021

Deciphering Potential Roles of Earthworms in Mitigation of Antibiotic Resistance in the Soils from Diverse Ecosystems

19 May 2021

Analyzing Empirical Quality Metrics of Deep Learning Models for Antimicrobial Resistance

19 May 2021

CARB-X IS FUNDING SUMMIT THERAPEUTICS TO DEVELOP A NEW ANTIBIOTIC TO TREAT MULTIDRUG-RESISTANT INFECTIONS CAUSED BY CARBAPENEM-RESISTANT ENTEROBACTERIACEAE (CRE)

19 May 2021

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

15 May 2021

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility

13 May 2021

Polypharmakos and CABI to develop new antimicrobial products from CABI Culture Collection

12 May 2021

CARB-X IS FUNDING AUSTRALIAN-BIOTECH SPEEDX TO DEVELOP A RAPID POINT-OF-CARE DIAGNOSTIC FOR SEXUALLY TRANSMITTED DISEASES CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE

11 May 2021

Successful Use of Telemedicine Infectious Diseases Consultation with an Antimicrobial Stewardship-Led Staphylococcus aureus Bacteremia Care Bundle

7 May 2021

More than 60 U.S. lawmakers urge House appropriators for more funds to address antimicrobial resistance

7 May 2021

Discovery may help boost peptide design

6 May 2021

The hidden pandemic: Innovate UK welcomes the global AMR community

6 May 2021

Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection

6 May 2021

Discovery That Antibiotic “Pops” Bacteria Could Lead to Improved Treatments for Superbugs

6 May 2021

Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance

5 May 2021

IIT Madras and U.K. Researchers Develop Paper-based Sensor to detect Antimicrobial Resistance triggering Pollutants

5 May 2021

BGU researchers develop antibiotic tweezers to battle resistant bacteria

5 May 2021

‘Last resort’ antibiotic pops bacteria like balloons

4 May 2021

Treating antibiotic resistance: Need for diagnostics and AI

3 May 2021

Medicines in Development for Antimicrobial Resistance (AMR) 2021 Report

30 April 2021

New PhRMA Report Shows Nearly 90 Medicines in Development to Fight Drug-Resistant Infections, but Future Pipeline Remains Challenging

29 April 2021

Pfizer buys Amplyx to expand drug-resistant treatment portfolio

29 April 2021

X-BIOTIX THERAPEUTICS ANNOUNCES CHANGE IN CORPORATE STRATEGY

28 April 2021

CARB-X IS FUNDING UK-BIOTECH GENOMEKEY TO DEVELOP A RAPID DIAGNOSTIC FOR SEPSIS, A LEADING CAUSE OF DEATH IN HOSPITALS

27 April 2021

Lack of Funding Drives Biotech to Suspend Drug-Resistant Antibiotic Pipeline

23 April 2021

“We Don’t Just Need a Few New Antibiotics, We Need an Arsenal”

22 April 2021

Antibiotic development, stewardship advocates see window of opportunity

20 April 2021

2020 antibacterial agents in clinical and preclinical development: an overview and analysis

20 April 2021

CARB-X IS FUNDING PHICO THERAPEUTICS TO DEVELOP AN ENGINEERED BACTERIOPHAGE DRUG TO TREAT VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

15 April 2021

BioVersys receives €20 million in EU financing to support development of new antibiotics

14 April 2021

Superbug killer: New nanotech destroys bacteria and fungal cells

10 April 2021

JPIAMR project dashboard published



What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed